{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37496822", "DateRevised": {"Year": "2023", "Month": "07", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "07", "Day": "18"}], "Language": ["eng"], "ELocationID": ["8618575", "10.1155/2023/8618575"], "Journal": {"ISSN": "1741-427X", "JournalIssue": {"Volume": "2023", "PubDate": {"Year": "2023"}}, "Title": "Evidence-based complementary and alternative medicine : eCAM", "ISOAbbreviation": "Evid Based Complement Alternat Med"}, "ArticleTitle": "Alpha-Lipoic Acid, Auraptene, and Particularly Their Combination Prevent the Metastasis of U87 Human Glioblastoma Cells.", "Pagination": {"StartPage": "8618575", "MedlinePgn": "8618575"}, "Abstract": {"AbstractText": ["The primary malignant brain tumor glioblastoma multiforme (GBM) is most commonly detected in individuals over 60\u2009years old. The standard therapeutic approach for GBM is radiotherapy combined with temozolomide. Recently, herbal products, such as alpha-lipoic acid (ALA) and auraptene (AUR), have shown promising anticancer effects on various cancer cells and animal models. However, it is not well understood how ALA, AUR, and their combination in GBM work to combat cancer. Thus, the purpose of this study was to investigate the antimetastatic effects of the ALA-AUR combination on U87 human glioblastoma cells.", "The inhibitory effects of ALA, AUR, and the ALA/AUR combination on the migration and metastasis of U87 cells were evaluated using a wound healing test and gelatin zymography. The expression levels of matrix metalloproteinase MMP-2 and MMP-9 were assessed at the transcriptional and translational levels using quantitative real-time polymerase chain reaction (qRT-PCR) and western blotting, respectively.", "Our findings revealed that combination therapy reduced cell migration and metastasis, which was indicated by the reduction in MMP-2/-9 expression both at mRNA and protein levels, as well as their enzymatic activity in U87 cells.", "This study demonstrated that the combination of ALA and AUR effectively inhibited the migration and metastasis of U87 cells. Thus, given their safety and favorable specifications, the combination of these drugs can be a promising candidate for GBM treatment as primary or adjuvant therapy."], "CopyrightInformation": "Copyright \u00a9 2023 Azam Izadi et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran."}], "LastName": "Izadi", "ForeName": "Azam", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Soukhtanloo", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran."}], "LastName": "Mirzavi", "ForeName": "Farshad", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Jalili-Nik", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": ["0000-0001-5241-9856"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Clinical Biochemistry, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran."}], "LastName": "Sadeghi", "ForeName": "Asie", "Initials": "A"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Evid Based Complement Alternat Med", "NlmUniqueID": "101215021", "ISSNLinking": "1741-427X"}, "CoiStatement": "The authors declare that there no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Afshari A. R., Sanati M., Aminyavari S., et al. Advantages and drawbacks of dexamethasone in glioblastoma multiforme. Critical Reviews in Oncology . 2022;172 doi: 10.1016/j.critrevonc.2022.103625.103625", "ArticleIdList": ["10.1016/j.critrevonc.2022.103625", "35158070"]}, {"Citation": "Davis M. E. Glioblastoma: overview of disease and treatment. Clinical Journal of Oncology Nursing . 2016;20(5):S2\u2013S8. doi: 10.1188/16.cjon.s1.2-8.", "ArticleIdList": ["10.1188/16.cjon.s1.2-8", "PMC5123811", "27668386"]}, {"Citation": "Yang S., Xie C., Guo T., et al. Simvastatin inhibits tumor growth and migration by mediating caspase-1-dependent pyroptosis in glioblastoma multiforme. World Neurosurgery . 2022;165:e12\u2013e21. doi: 10.1016/j.wneu.2022.03.089.", "ArticleIdList": ["10.1016/j.wneu.2022.03.089", "35342027"]}, {"Citation": "Maghrouni A., Givari M., Jalili-Nik M., et al. Targeting the PD-1/PD-L1 pathway in glioblastoma multiforme: preclinical evidence and clinical interventions. International Immunopharmacology . 2021;93 doi: 10.1016/j.intimp.2021.107403.107403", "ArticleIdList": ["10.1016/j.intimp.2021.107403", "33581502"]}, {"Citation": "Afshari A. R., Motamed-Sanaye A., Sabri H., et al. Neurokinin-1 receptor (NK-1R) antagonists: potential targets in the treatment of glioblastoma multiforme. Current Medicinal Chemistry . 2021;28(24):4877\u20134892. doi: 10.2174/0929867328666210113165805.", "ArticleIdList": ["10.2174/0929867328666210113165805", "33441062"]}, {"Citation": "Jalili-Nik M., Afshari A. R., Sabri H., Bibak B., Mollazadeh H., Sahebkar A. Zerumbone, a ginger sesquiterpene, inhibits migration, invasion, and metastatic behavior of human malignant glioblastoma multiforme in vitro. BioFactors . 2021;47(5):729\u2013739. doi: 10.1002/biof.1756.", "ArticleIdList": ["10.1002/biof.1756", "34046952"]}, {"Citation": "Ye J., Zhang R., Wu F., et al. Non-apoptotic cell death in malignant tumor cells and natural compounds. Cancer Letters . 2018;420:210\u2013227. doi: 10.1016/j.canlet.2018.01.061.", "ArticleIdList": ["10.1016/j.canlet.2018.01.061", "29410006"]}, {"Citation": "Yuan H., Ma Q., Ye L., Piao G. The traditional medicine and modern medicine from natural products. Molecules . 2016;21(5):p. 559. doi: 10.3390/molecules21050559.", "ArticleIdList": ["10.3390/molecules21050559", "PMC6273146", "27136524"]}, {"Citation": "Kuban-Jankowska A., Gorska-Ponikowska M., Wozniak M. Lipoic acid decreases the viability of breast cancer cells and activity of PTP1B and SHP2. Anticancer Research . 2017;37(6):2893\u20132898. doi: 10.21873/anticanres.11642.", "ArticleIdList": ["10.21873/anticanres.11642", "28551626"]}, {"Citation": "El Barky A., Hussein S., Mohamed T. The potent antioxidant alpha lipoic acid. J Plant Chem Ecophysiol . 2017;2:p. 1016."}, {"Citation": "Cremer D., Rabeler R., Roberts A., Lynch B. Safety evaluation of \u03b1-lipoic acid (ALA) Regulatory Toxicology and Pharmacology . 2006;46(1):29\u201341. doi: 10.1016/j.yrtph.2006.06.004.", "ArticleIdList": ["10.1016/j.yrtph.2006.06.004", "16904799"]}, {"Citation": "Reljanovic M., Reichel G., Rett K., et al. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (\u03b1-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II) Free Radical Research . 1999;31(3):171\u2013179. doi: 10.1080/10715769900300721.", "ArticleIdList": ["10.1080/10715769900300721", "10499773"]}, {"Citation": "Costantino M., Guaraldi C., Costantino D., De Grazia S., Unfer V. Peripheral neuropathy in obstetrics: efficacy and safety of \u03b1-lipoic acid supplementation. European Review for Medical and Pharmacological Sciences . 2014;18(18):2766\u20132771.", "ArticleIdList": ["25317815"]}, {"Citation": "Gomes M. B., Negrato C. A. Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases. Diabetology & Metabolic Syndrome . 2014;6(1):80\u201318. doi: 10.1186/1758-5996-6-80.", "ArticleIdList": ["10.1186/1758-5996-6-80", "PMC4124142", "25104975"]}, {"Citation": "Najafi N., Mehri S., Ghasemzadeh Rahbardar M., Hosseinzadeh H. Effects of alpha lipoic acid on metabolic syndrome: a comprehensive review. Phytotherapy Research . 2022;36(6):2300\u20132323. doi: 10.1002/ptr.7406.", "ArticleIdList": ["10.1002/ptr.7406", "35234312"]}, {"Citation": "Akbari M., Ostadmohammadi V., Tabrizi R., et al. The effects of alpha-lipoic acid supplementation on inflammatory markers among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials. Nutrition and Metabolism . 2018;15(1):p. 39. doi: 10.1186/s12986-018-0274-y.", "ArticleIdList": ["10.1186/s12986-018-0274-y", "PMC5989440", "29930690"]}, {"Citation": "Packer L., Witt E. H., Tritschler H. J. alpha-Lipoic acid as a biological antioxidant. Free Radical Biology and Medicine . 1995;19(2):227\u2013250. doi: 10.1016/0891-5849(95)00017-r.", "ArticleIdList": ["10.1016/0891-5849(95)00017-r", "7649494"]}, {"Citation": "Attia M., Essa E. A., Zaki R. M., Elkordy A. A. An overview of the antioxidant effects of ascorbic acid and alpha lipoic acid (in liposomal forms) as adjuvant in cancer treatment. Antioxidants . 2020;9(5):p. 359. doi: 10.3390/antiox9050359.", "ArticleIdList": ["10.3390/antiox9050359", "PMC7278686", "32344912"]}, {"Citation": "Yoo T. H., Lee J. H., Chun H. S., Chi S. G. \u03b1-Lipoic acid prevents p53 degradation in colon cancer cells by blocking NF-\u03baB induction of RPS6KA4. Anti-Cancer Drugs . 2013;24(6):555\u2013565. doi: 10.1097/cad.0b013e32836181eb.", "ArticleIdList": ["10.1097/cad.0b013e32836181eb", "23599020"]}, {"Citation": "Farhat D., Lincet H. Lipoic acid a multi-level molecular inhibitor of tumorigenesis, Biochimica et Biophysica Acta: Reviews on Cancer . 2020;1873(1):p. 188317. doi: 10.1016/j.bbcan.2019.188317.", "ArticleIdList": ["10.1016/j.bbcan.2019.188317", "31669587"]}, {"Citation": "Jeon M. J., Kim W. G., Lim S., et al. Alpha lipoic acid inhibits proliferation and epithelial mesenchymal transition of thyroid cancer cells. Molecular and Cellular Endocrinology . 2016;419:113\u2013123. doi: 10.1016/j.mce.2015.10.005.", "ArticleIdList": ["10.1016/j.mce.2015.10.005", "26463583"]}, {"Citation": "Halbersztadt A., Halo\u0144 A., Pajak J., Robaczy\u0144ski J., Rabczynski J., St Gabry\u015b M. The role of matrix metalloproteinases in tumor invasion and metastasis. Ginekologia Polska . 2006;77(1):63\u201371.", "ArticleIdList": ["16736963"]}, {"Citation": "Conlon G. A., Murray G. I. Recent advances in understanding the roles of matrix metalloproteinases in tumour invasion and metastasis. The Journal of Pathology . 2019;247(5):629\u2013640. doi: 10.1002/path.5225.", "ArticleIdList": ["10.1002/path.5225", "30582157"]}, {"Citation": "Kim H.-S., Kim H.-J., Park K.-G., et al. \u03b1-Lipoic acid inhibits matrix metalloproteinase-9 expression by inhibiting NF-\u03baB transcriptional activity. Experimental and Molecular Medicine . 2007;39(1):106\u2013113. doi: 10.1038/emm.2007.12.", "ArticleIdList": ["10.1038/emm.2007.12", "17334234"]}, {"Citation": "Tripathy J., Tripathy A., Thangaraju M., Suar M., Elangovan S. \u03b1-Lipoic acid inhibits the migration and invasion of breast cancer cells through inhibition of TGF\u03b2 signaling. Life Sciences . 2018;207:15\u201322. doi: 10.1016/j.lfs.2018.05.039.", "ArticleIdList": ["10.1016/j.lfs.2018.05.039", "29802942"]}, {"Citation": "Lee H. S., Na M. H., Kim W. K. \u03b1-Lipoic acid reduces matrix metalloproteinase activity in MDA-MB-231 human breast cancer cells. Nutrition Research . 2010;30(6):403\u2013409. doi: 10.1016/j.nutres.2010.06.009.", "ArticleIdList": ["10.1016/j.nutres.2010.06.009", "20650348"]}, {"Citation": "Damnjanovic I., Kocic G., Najman S. Possible Molecular Mechanisms and Pathways Involved in BH3 Mimetic Activity of Alpha-Lipoic Acid on Human colon Cancer Cell Line. Farmacia . 2019;2"}, {"Citation": "Na M. H., Seo E. Y., Kim W. K. Effects of alpha-lipoic acid on cell proliferation and apoptosis in MDA-MB-231 human breast cells. Nutrition Research and Practice . 2009;3(4):265\u2013271. doi: 10.4162/nrp.2009.3.4.265.", "ArticleIdList": ["10.4162/nrp.2009.3.4.265", "PMC2809232", "20098578"]}, {"Citation": "Curini M., Cravotto G., Epifano F., Giannone G. Chemistry and biological activity of natural and synthetic prenyloxycoumarins. Current Medicinal Chemistry . 2006;13(2):199\u2013222. doi: 10.2174/092986706775197890.", "ArticleIdList": ["10.2174/092986706775197890", "16472213"]}, {"Citation": "Vakili T., Iranshahi M., Arab H., Riahi B., Roshan N. M., Karimi G. Safety evaluation of auraptene in rats in acute and subacute toxicity studies. Regulatory Toxicology and Pharmacology . 2017;91:159\u2013164. doi: 10.1016/j.yrtph.2017.10.025.", "ArticleIdList": ["10.1016/j.yrtph.2017.10.025", "29080847"]}, {"Citation": "Mousavi S. H., Davari A. S., Iranshahi M., Sabouri-Rad S., Tayarani Najaran Z. Comparative analysis of the cytotoxic effect of 7-prenyloxycoumarin compounds and herniarin on MCF-7 cell line. Avicenna J Phytomed . 2015;5(6):520\u2013530.", "ArticleIdList": ["PMC4678497", "26693409"]}, {"Citation": "Fiorito S., Preziuso F., Sharifi-Rad M., Marchetti L., Epifano F., Genovese S. Auraptene and umbelliprenin: a review on their latest literature acquisitions. Phytochemistry Reviews . 2022;21(2):317\u2013326. doi: 10.1007/s11101-020-09713-5.", "ArticleIdList": ["10.1007/s11101-020-09713-5"]}, {"Citation": "Genovese S., Epifano F. Auraptene: a natural biologically active compound with multiple targets. Current Drug Targets . 2011;12(3):381\u2013386. doi: 10.2174/138945011794815248.", "ArticleIdList": ["10.2174/138945011794815248", "20955144"]}, {"Citation": "Tayarani-Najaran Z., Tayarani-Najaran N., Eghbali S. A review of auraptene as an anticancer agent. Frontiers in Pharmacology . 2021;12 doi: 10.3389/fphar.2021.698352.698352", "ArticleIdList": ["10.3389/fphar.2021.698352", "PMC8258114", "34239445"]}, {"Citation": "Krishnan P., Yan K. J., Windler D., et al. Citrus auraptene suppresses cyclin D1 and significantly delays N-methyl nitrosourea induced mammary carcinogenesis in female Sprague-Dawley rats. BMC Cancer . 2009;9(1):p. 259. doi: 10.1186/1471-2407-9-259.", "ArticleIdList": ["10.1186/1471-2407-9-259", "PMC2724550", "19640308"]}, {"Citation": "Abroudi M., Dadashizadeh G., Sam\u2019e M. Antiproliferative effects of different concentrations of auraptene on MCF7 cancer cell line. Middle East Journal of Cancer . 2022;13(3):411\u2013417."}, {"Citation": "Jamialahmadi K., Salari S., Alamolhodaei N. S., Avan A., Gholami L., Karimi G. Auraptene inhibits migration and invasion of cervical and ovarian cancer cells by repression of matrix metalloproteinasas 2 and 9 activity. Journal of Pharmacopuncture . 2018;21(3):177\u2013184. doi: 10.3831/kpi.2018.21.021.", "ArticleIdList": ["10.3831/kpi.2018.21.021", "PMC6168187", "30283705"]}, {"Citation": "Charmforoshan E., Karimi E., Oskoueian E., Es-Haghi A., Iranshahi M. Inhibition of human breast cancer cells (MCF-7 cell line) growth via cell proliferation, migration, and angiogenesis by auraptene of Ferula szowitsiana root extract. Journal of Food Measurement and Characterization . 2019;13(4):2644\u20132653. doi: 10.1007/s11694-019-00185-6.", "ArticleIdList": ["10.1007/s11694-019-00185-6"]}, {"Citation": "Kawabata K., Murakami A., Ohigashi H. Auraptene decreases the activity of matrix metalloproteinases in dextran sulfate sodium-induced ulcerative colitis in ICR mice. Bioscience, Biotechnology, and Biochemistry . 2006;70(12):3062\u20133065. doi: 10.1271/bbb.60393.", "ArticleIdList": ["10.1271/bbb.60393", "17151446"]}, {"Citation": "Lee J. C., Shin E. A., Kim B., et al. Auraptene induces apoptosis via myeloid cell leukemia 1-mediated activation of caspases in PC3 and DU145 prostate cancer cells. Phytotherapy Research . 2017;31(6):891\u2013898. doi: 10.1002/ptr.5810.", "ArticleIdList": ["10.1002/ptr.5810", "28383142"]}, {"Citation": "Naseri M. H., Mahdavi M., Davoodi J., Tackallou S. H., Goudarzvand M., Neishabouri S. H. Up regulation of Bax and down regulation of Bcl2 during 3-NC mediated apoptosis in human cancer cells. Cancer Cell International . 2015;15(1):p. 55. doi: 10.1186/s12935-015-0204-2.", "ArticleIdList": ["10.1186/s12935-015-0204-2", "PMC4464715", "26074734"]}, {"Citation": "Kupai K., Szucs G., Cseh S., et al. Matrix metalloproteinase activity assays: importance of zymography. Journal of Pharmacological and Toxicological Methods . 2010;61(2):205\u2013209. doi: 10.1016/j.vascn.2010.02.011.", "ArticleIdList": ["10.1016/j.vascn.2010.02.011", "20176119"]}, {"Citation": "Hozhabri Y., Sadeghi A., Nazari-Robati M., et al. Effects of trehalose on NFE2L2, catalase, and superoxide dismutase in the kidney of aged rats. Molecular Biology Research Communications . 2022;11(1):29\u201336. doi: 10.22099/mbrc.2022.42014.1688.", "ArticleIdList": ["10.22099/mbrc.2022.42014.1688", "PMC9012427", "35463818"]}, {"Citation": "Sadeghi A., Shabani M., Alizadeh S., Meshkani R. Interplay between oxidative stress and autophagy function and its role in inflammatory cytokine expression induced by palmitate in skeletal muscle cells. Cytokine . 2020;125 doi: 10.1016/j.cyto.2019.154835.154835", "ArticleIdList": ["10.1016/j.cyto.2019.154835", "31479873"]}, {"Citation": "Yamaguchi H., Wyckoff J., Condeelis J. Cell migration in tumors. Current Opinion in Cell Biology . 2005;17(5):559\u2013564. doi: 10.1016/j.ceb.2005.08.002.", "ArticleIdList": ["10.1016/j.ceb.2005.08.002", "16098726"]}, {"Citation": "Fares J., Fares M. Y., Khachfe H. H., Salhab H. A., Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduction and Targeted Therapy . 2020;5(1):p. 28. doi: 10.1038/s41392-020-0134-x.", "ArticleIdList": ["10.1038/s41392-020-0134-x", "PMC7067809", "32296047"]}, {"Citation": "Nguyen H., Gupta V. StatPearls . Tampa, FL, USA: StatPearls Publishing; 2022. Alpha-lipoic acid.", "ArticleIdList": ["33231971"]}, {"Citation": "Yamasaki M., Iwase M., Kawano K., et al. \u03b1-Lipoic acid suppresses migration and invasion via downregulation of cell surface \u03b21-integrin expression in bladder cancer cells. Journal of Clinical Biochemistry and Nutrition . 2013;54(1):18\u201325. doi: 10.3164/jcbn.13-57.", "ArticleIdList": ["10.3164/jcbn.13-57", "PMC3882485", "24426186"]}, {"Citation": "Voronkina I., Kirpichnikova K., Smagina L., Gamaley I. Activity of matrix metalloproteinases in normal and transformed mouse fibroblasts exposed to antioxidants. Cell and Tissue Biology . 2009;3(1):56\u201360. doi: 10.1134/s1990519x09010088.", "ArticleIdList": ["10.1134/s1990519x09010088"]}, {"Citation": "Ohigashi H. Citrus auraptene targets translation of MMP-7 (matrilysin) via ERK1/2-dependent and mTOR-independent mechanism. FEBS Letters . 2006;30580(622):5288\u20135294. doi: 10.1016/j.febslet.2006.08.072.", "ArticleIdList": ["10.1016/j.febslet.2006.08.072", "16979634"]}, {"Citation": "Marquis A., Genovese S., Epifano F., Grenier D. The plant coumarins auraptene and lacinartin as potential multifunctional therapeutic agents for treating periodontal disease. BMC Complementary and Alternative Medicine . 2012;12(1):p. 80. doi: 10.1186/1472-6882-12-80.", "ArticleIdList": ["10.1186/1472-6882-12-80", "PMC3489859", "22742512"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "3", "Day": "17"}, {"Year": "2023", "Month": "6", "Day": "10"}, {"Year": "2023", "Month": "7", "Day": "3"}, {"Year": "2023", "Month": "7", "Day": "27", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "7", "Day": "27", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "7", "Day": "27", "Hour": "4", "Minute": "9"}, {"Year": "2023", "Month": "7", "Day": "18"}], "PublicationStatus": "epublish", "ArticleIdList": ["37496822", "PMC10368506", "10.1155/2023/8618575"]}}], "PubmedBookArticle": []}